Fig. 3
From: Real-world evidence of fremanezumab for treating migraine in Japan: a retrospective study
Efficacy of fremanezumab in patients with EM and CM. a Changes in MMD from baseline. *Significant difference compared with baseline. * adjusted p < 0.05; **adjusted p < 0.01; ***adjusted p < 0.001. Error bars represent 95% confidence interval. Abbreviations: MMD, monthly migraine day; EM, episodic migraine; CM, chronic migraine; 1 M, 1 month; 2 M, 2 months; 3 M, 3 months; 4 M, 4 months. b Responder rates. Proportion of patients with responder rates of 25%, 50%, 75%, and 100%. Abbreviations: EM, episodic migraine; CM, chronic migraine; 1 M, 1 month; 2 M, 2 months; 3 M, 3 months; 4 M, 4 months; RR, responder rate